Elisabeth Roider, MD, PhD, MBA

Dermatologist • scientist • investor • founder | Skin • Longevity | Harvard • Basel | EMR BioHealth • InnoMed Advisors • Nescens | Building the future of health

[Longevity Investors @Longevity_Inv]

💫A huge THANK YOU to our amazing partners for making LIC 2025 possible!

Your support fuels our mission to bring the longevity community together in Gstaad for another unforgettable year. With your vision and collaboration, we’re not just talking about the future of longevity — we’re building it.

@BellevueGstaad
@maximon_ag
@BioResetMedical
AIage Life
@tomorrowbio
Symptomedica
QurisAI
Exceptional Ventures
YMS
InnoMed Advisors
@MaerkiBaumann
@OisinBio
@AveaLife
AYUN
@LifespanNews
Haute Aviation
Silversport

#LIC2025 #LongevityInvestors

[Longevity Investors @Longevity_Inv]

We’re proud to welcome InnoMed Advisors as a partner of LIC 2025! 🤝✨

Represented by Dr. Elisabeth Roider — physician-scientist, entrepreneur & investor shaping the future of longevity by bridging science and capital. 🌍🧬

#LIC2025 #LongevityInvestors

[Maximon @maximon_ag]

🌟 𝑫𝒐𝒏’𝒕 𝒅𝒊𝒆: 𝑳𝒐𝒏𝒈𝒆𝒗𝒊𝒕𝒚 𝒑𝒊𝒐𝒏𝒆𝒆𝒓𝒔 𝒐𝒏 𝒕𝒉𝒆 𝒆𝒅𝒈𝒆 𝒐𝒇 𝒆𝒕𝒆𝒓𝒏𝒊𝒕𝒚 – HLTH Europe, 17 June 2025
Two days ago, our Founding Partner Elisabeth Roider, MD, PhD, MBA , also Founder at InnoMed Advisors, joined an eye-opening panel at 𝐇𝐋𝐓𝐇 𝐄𝐮𝐫𝐨𝐩𝐞, moderated by Alexa Mikhail from Fortune Magazine, alongside: Terry Doyle, Managing Partner at TELUS Global Ventures (TGV), and Alyssa Jaffee, Partner at 7wire Ventures.
The conversation ventured beyond the familiar “𝘦𝘢𝘵 𝘮𝘰𝘳𝘦 𝘷𝘦𝘨𝘨𝘪𝘦𝘴 𝘢𝘯𝘥 𝘨𝘦𝘵 𝘮𝘰𝘳𝘦 𝘴𝘭𝘦𝘦𝘱” approach to longevity, diving into radical biohacks and even science-fiction-worthy concepts like multi-generational plasma exchange. These frontier methods, while currently expensive and out of reach for public health systems, hold transformative potential as data and innovation drive costs down and open the door to broader accessibility.
Elisabeth brought her unique perspective on how the longevity ecosystem needs to:
1️⃣ Balance cutting-edge methods with real-world scalability
2️⃣ Leverage data to move breakthroughs from niche to mainstream
3️⃣ Ensure innovations benefit more than just the ultra-wealthy
As longevity research accelerates, voices like Elisabeth’s are critical in steering a future where these breakthroughs are not just possible but equitable.

[Elisabeth Roider, MD, PhD, MBA @dr_roider]

@PawlowskiMario Well written

[Elisabeth Roider, MD, PhD, MBA @dr_roider]

@JDVance Wise men speak because they have something to say; fools because they have to say something.

[Harvard University @Harvard]

Without its international students, Harvard is not Harvard. https://t.co/V8uvTNaL64

[CNN @CNN]

The Trump administration announced it is cutting off all new federal research grants to Harvard University as it pushes for policy changes
https://t.co/tAMaBaZWSV

[Harvard University @Harvard]

“No government—regardless of which party is in power—should dictate what private universities can teach, whom they can admit and hire, and which areas of study and inquiry they can pursue.” - President Alan Garber https://t.co/6cQQpcJVTd

[Danielle Beckman @DaniBeckman]

Fantastic study published in @Nature. In times of anti-science and anti-vax movement, more evidence points to viruses affecting your brain and contributing to dementia, and vaccines sometimes can help prevent this. This is the type of research we are cutting in the U.S.

[Elisabeth Roider, MD, PhD, MBA @dr_roider]

@sama @Sohail_NITIE Research confirms X’s algorithms amplify aggressive, toxic, and negatively charged content, especially anger and hostility, due to higher user engagement (Huszár et al., 2024; DeVerna et al., 2024; Rathje et al., 2023).

[Elsa Logarinho @ELogarinho]

Many thanks to @maximon_ag for the Maximon Longevity prize that made this work possible 🙏
Congratulations to all authors 👏👏👏

[Eric Topol @EricTopol]

Does intermittent fasting improve health outcomes?
It's not clearcut.
A very good review of what is known. @Nature
open-access. https://t.co/pGNUP7PPaQ

[Elisabeth Roider, MD, PhD, MBA @dr_roider]

Dr. He’s gene editing was medically unnecessary and conducted without proper oversight. He was rightly sentenced to three years in jail for illegal medical practice. Nevertheless, human germline editing is likely inevitable, so establishing ethical frameworks sooner rather than later is crucial.

[Science Magazine @ScienceMagazine]

Can internet use become addictive?

A #SciencePerspective discusses the addictive potential of the #internet and how it can be best conceptualized and evaluated. https://t.co/QmkqtTuU6T #BrainAwarenessWeek

[Elisabeth Roider, MD, PhD, MBA @dr_roider]

Thank you, Dominik Thor, for organizing and facilitating such a valuable discussion on longevity markets in the Middle East.

A special thanks to Ali Hashemi, Shannon Neilsen, Rams Kanouni for the insightful conversation—it was a pleasure to exchange ideas and perspectives.

Exciting times ahead for @maximon_ag and the Geneva College of Longevity Science!

[Elisabeth Roider, MD, PhD, MBA @dr_roider]

On stage with the pioneers who have shaped and continue to shape dermatology and regenerative medicine.

With Dr. Mathew Avram, Dr. Dieter Manstein, Dr. Jean Carruthers, and Dr. Kathy Fields at #IMCAS 2025 in Paris.

[Elisabeth Roider, MD, PhD, MBA @dr_roider]

@holisticgrenade We have a paper on that question https://t.co/FaMxsHkHnI

[Elisabeth Roider, MD, PhD, MBA @dr_roider]

@IfindRetards Retard is a medical term for a person with intellectual disabilities. The people you tag are not suffering from intellectual disability.

[Maximon @maximon_ag]

Maximon at #GCLS2025 – Shaping the Future of Health & Longevity in the Middle East

The longevity revolution is here, and we’re excited to be part of it!
Maximon’s Partner Dr. Elisabeth Roider @dr_roider is attending "Shaping the Future of Health and Longevity in the Middle East," conference, hosted by the Geneva College of Longevity Science (GCLS), in Dubai through 13-14 February.
She will share her insights, alongside Ali Hashemi, Shannon Neilsen, Rams Kanouni and Shahrukh Hashmi in the Panel Discussion: “Longevity Markets in the Middle East”

They’ll explore:
💡 The evolving longevity landscape in the region
📊 Investment & business opportunities
🌍 The role of research, innovation & policy in shaping healthspan

At Maximon, we’re driving the longevity economy by turning breakthrough science into impactful businesses. Looking forward to connecting with fellow innovators at #GCLS2025!
#longevity
#LongevityInvesting

[Maximon @maximon_ag]

Maximon at
#Hevolution2025

The countdown is on! In just a few days, the Global Healthspan Summit 2025 organized by the Hevolution Foundation @hevolution_f will bring together world-class experts, investors, and innovators in Riyadh to drive the next wave of longevity breakthroughs.

At The Investment Exchange panel discussion, Marc P. Bernegger @marcpbernegger Founder of Maximon & Longevity Investors, will join: Zack Lynch @neurorev Managing Director JAZZ Venture Partners, Dr. Hannah Mamuszka, Founder & CEO ALVA10, Vijay Pande PhD @vijaypande Founder of a16z Bio + Health and Dr. Amol Sarva @amol Managing Partner LifeX Ventures. Together they will share their perspective on the evolving longevity investment landscape, moderated by Dr. William Greene, CIO of the Hevolution Foundation. With their profound knowledge and experience in this field, they will dive into:

💡 The evolving landscape of longevity investments
📈 Key trends and opportunities in healthspan-focused startups
🌍 How global ecosystems—from Silicon Valley to the Middle East—are shaping the future of the industry

Maximon is dedicated to pioneering the longevity economy, turning cutting-edge science into scalable, high-impact businesses. We look forward to connecting with fellow visionaries at GHS2025 and continuing our mission to empower founders in this transformative field.

#LongevityInvesting
#GlobalHealthspanSummit
#GHS2025